Novartis halts experimental cell therapy trials after deaths
Kort samengevat
Novartis has halted eight clinical trials of its experimental cell therapy rap-cel after three patients experienced severe, life-threatening immune reactions that led to their deaths
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Japan Herald.
Lees het volledige bericht ↗